DNA X, Inc. quarterly report, Q2 FY2019

Business context and reporting period

Filing identity: The supplied metadata names DNA X, Inc., but this Form 10-Q identifies the registrant as Sonim Technologies, Inc. (Nasdaq: SONM). Verify that this is the intended filing. The report covers the quarter and six months ended June 30, 2019; dollar amounts below are in U.S. dollars and generally in millions.

Sonim sells ultra-rugged mobile phones and accessories, primarily through wireless carriers, for industrial enterprise and public-sector users. It completed its IPO in May 2019.

Financial performance and position

Q2 revenue rose 39%; first-half revenue rose 41%. Growth was attributed to higher XP8 and XP5s shipments and XP3 launches. First-half unit sales nearly doubled to approximately 223,000 from 112,000, driven by feature phones. Q2 diluted loss per share was $0.34, versus $3.01; first-half loss per share was $0.73, versus $10.78. Comparisons are affected by the 2019 IPO and prior-period preferred-stock structure.

At June 30, cash and equivalents were $15.7, versus $13.0 at December 31, 2018. Current assets were $83.0 and current liabilities $36.8, implying working capital of approximately $46.1. Accounts receivable was $31.3 and inventory $26.5. Total liabilities were $50.8; balance-sheet debt was $13.3, including current and long-term portions. The $12.0 B. Riley note carried $1.1 of accrued interest; the $8.0 East West Bank credit line was undrawn, with $8.0 available.

For the first half, operating cash use was $34.8, investing cash use $0.5, and financing cash provided $37.9. Operating cash use included substantial working-capital outflows, notably higher receivables and inventory and lower payables and deferred revenue. IPO proceeds were approximately $36.8 net of underwriting and offering expenses; cash-flow reporting also reflects issuance costs not yet paid at period-end.

Material changes versus the prior comparable period

• Revenue growth and improved first-half gross margin were accompanied by higher operating expenses and a larger net loss.
• Q2 operating expenses doubled year over year. General and administrative costs rose sharply, including IPO-related executive stock compensation; total first-half stock-based compensation was $5.6, versus $0.1 in 2018.
• Feature phones were about 77% of Q2 unit sales, versus 46% a year earlier; smartphone unit sales declined.
• Cash increased following the IPO, but first-half operating cash burn rose markedly from $4.9 to $34.8.

Outlook, risks, contingencies, and unusual items

• Management said existing cash and expected operating cash generation should cover anticipated requirements for at least the next 12 months. The filing gives no numerical revenue or earnings guidance.
• Management cited continued investment in R&D, sales and marketing, and growth. Key risks include dependence on a small number of carrier customers, purchase-order-based sales without firm minimum volumes, product certification and supply constraints, competition, and tariff exposure related to manufacturing in China.
• Three customers represented 46%, 37%, and 6% of receivables at June 30. The top five customers accounted for 82% of first-half revenue. These concentrations heighten customer and collection risk.
• After quarter-end, the company repaid $3.25 of principal on the B. Riley note. The note otherwise matures in September 2022; the East West Bank line matures in November 2019. The company reported compliance with financial covenants at June 30.
• The company disclosed ordinary-course litigation and intellectual-property indemnification obligations, but no pending legal proceeding expected to have a material adverse effect. It reported approximately $6.0 of gross unrecognized tax benefits and no expected material change in uncertain tax positions over the next 12 months.
• Management reported disclosure controls effective at the reasonable-assurance level and no material quarterly change in internal control. The risk factors also disclose two previously identified material weaknesses concerning revenue recognition and inventory reporting, with remediation efforts underway.

Important facts for investors to verify

• Confirm the registrant identity: the filing is for Sonim Technologies, Inc., not DNA X, Inc.
• Reconcile the scale and sustainability of operating cash burn with management’s stated 12-month liquidity expectation, including receivable collections and inventory needs.
• Assess customer and carrier concentration, particularly the large share of revenue and receivables attributable to a few customers.
• Review the post-quarter $3.25 debt repayment, remaining B. Riley note balance and terms, and the November 2019 credit-line maturity.
• Track whether revenue-recognition and inventory-control weaknesses are fully remediated, and distinguish recurring operating costs from IPO-related stock compensation.